Future Fund LLC lifted its holdings in shares of HealthEquity, Inc. (NASDAQ:HQY – Free Report) by 40.9% in the 4th quarter, HoldingsChannel.com reports. The institutional investor owned 44,317 shares of the company’s stock after acquiring an additional 12,854 shares during the period. HealthEquity accounts for approximately 1.4% of Future Fund LLC’s portfolio, making the stock its 10th biggest holding. Future Fund LLC’s holdings in HealthEquity were worth $4,060,000 at the end of the most recent quarter.
Several other hedge funds and other institutional investors have also made changes to their positions in HQY. William Blair Investment Management LLC acquired a new position in shares of HealthEquity during the fourth quarter worth approximately $169,956,000. AQR Capital Management LLC boosted its position in shares of HealthEquity by 148.5% during the second quarter. AQR Capital Management LLC now owns 1,107,448 shares of the company’s stock worth $116,016,000 after buying an additional 661,795 shares during the period. Northwestern Mutual Wealth Management Co. boosted its position in shares of HealthEquity by 229,985.6% during the fourth quarter. Northwestern Mutual Wealth Management Co. now owns 478,578 shares of the company’s stock worth $43,843,000 after buying an additional 478,370 shares during the period. Westfield Capital Management Co. LP boosted its position in shares of HealthEquity by 35.7% during the third quarter. Westfield Capital Management Co. LP now owns 1,716,658 shares of the company’s stock worth $162,688,000 after buying an additional 451,450 shares during the period. Finally, Swedbank AB bought a new stake in HealthEquity during the fourth quarter worth approximately $40,061,000. 99.55% of the stock is currently owned by institutional investors and hedge funds.
HealthEquity Price Performance
Shares of NASDAQ:HQY opened at $87.99 on Friday. The company’s fifty day moving average is $83.44 and its two-hundred day moving average is $86.77. The company has a quick ratio of 3.27, a current ratio of 3.27 and a debt-to-equity ratio of 0.45. HealthEquity, Inc. has a 12-month low of $72.76 and a 12-month high of $116.65. The company has a market cap of $7.38 billion, a P/E ratio of 32.96, a price-to-earnings-growth ratio of 1.65 and a beta of 0.19.
Wall Street Analyst Weigh In
Several brokerages recently commented on HQY. UBS Group set a $110.00 target price on HealthEquity in a report on Tuesday, February 17th. BTIG Research cut their price objective on HealthEquity from $130.00 to $110.00 and set a “buy” rating for the company in a research report on Tuesday, February 17th. Jefferies Financial Group set a $108.00 price objective on HealthEquity in a research report on Thursday, February 19th. Wall Street Zen downgraded HealthEquity from a “buy” rating to a “hold” rating in a research report on Saturday, May 9th. Finally, Royal Bank Of Canada increased their price objective on HealthEquity from $100.00 to $108.00 and gave the company an “outperform” rating in a research report on Friday. One research analyst has rated the stock with a Strong Buy rating, twelve have issued a Buy rating, one has issued a Hold rating and one has given a Sell rating to the company. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $112.36.
Read Our Latest Analysis on HealthEquity
Trending Headlines about HealthEquity
Here are the key news stories impacting HealthEquity this week:
- Positive Sentiment: HealthEquity beat Q1 FY27 expectations, reporting $1.24 EPS on $354.6 million in revenue, with revenue up 7.2% year over year and net income up 29%; the company also raised its full-year outlook. HealthEquity Reports First Quarter Ended April 30, 2026 Financial Results; Raises Guidance
- Positive Sentiment: The company expanded its share repurchase authorization by $1 billion, which can support per-share earnings and signals confidence in future cash generation. HealthEquity outlines fiscal 2027 revenue of $1.41B-$1.42B while expanding share repurchase authorization by $1B
- Positive Sentiment: Royal Bank of Canada raised its price target on HealthEquity to $108 from $100 and reiterated an outperform rating, implying further upside from current levels. Benzinga
- Neutral Sentiment: Earnings call coverage and transcript articles highlighted management commentary, but did not add materially new investor information beyond the reported results and guidance. HealthEquity, Inc. (HQY) Q1 2027 Earnings Call Transcript
- Neutral Sentiment: Short-interest data showed no meaningful change to the stock’s trading backdrop. HealthEquity (NASDAQ:HQY) – Get Free Report
About HealthEquity
HealthEquity, Inc (NASDAQ: HQY) is a leading administrator of consumer-directed health accounts and related benefit solutions in the United States. Founded in 2002 and headquartered in Draper, Utah, the company specializes in health savings accounts (HSAs) and offers complementary services such as flexible spending accounts (FSAs), health reimbursement arrangements (HRAs), COBRA administration and commuter benefits. Through its technology-driven platform, HealthEquity enables employers, health plans and individuals to streamline account management, improve cost transparency and encourage more informed healthcare spending.
Serving millions of members across all 50 states, HealthEquity leverages an open-architecture ecosystem that integrates with health plans, payroll providers and financial institutions.
See Also
- Five stocks we like better than HealthEquity
- Shares Fall, Targets Rise—Markets and Analysts Diverge on Synopsys
- Salesforce Stock Finds Support as AI Momentum Builds
- Dollar Tree Keeps Winning After Family Dollar Divorce
- Apple’s Agentic AI Plans Could Be Its Biggest Growth Story Yet
Want to see what other hedge funds are holding HQY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HealthEquity, Inc. (NASDAQ:HQY – Free Report).
Receive News & Ratings for HealthEquity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HealthEquity and related companies with MarketBeat.com's FREE daily email newsletter.
